PL437487A1 - Pharmaceutical composition and its antiviral application - Google Patents

Pharmaceutical composition and its antiviral application

Info

Publication number
PL437487A1
PL437487A1 PL437487A PL43748721A PL437487A1 PL 437487 A1 PL437487 A1 PL 437487A1 PL 437487 A PL437487 A PL 437487A PL 43748721 A PL43748721 A PL 43748721A PL 437487 A1 PL437487 A1 PL 437487A1
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
subject
antiviral application
composition
extract
Prior art date
Application number
PL437487A
Other languages
Polish (pl)
Inventor
Krzysztof Lemke
Paulina Kowalczyk
Barbara KHAIDAKOV
Aleksandra BOJARCZUK
Mariusz Banach
Wojciech Cyplik
Original Assignee
Aronpharma Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aronpharma Spółka Z Ograniczoną Odpowiedzialnością filed Critical Aronpharma Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL437487A priority Critical patent/PL437487A1/en
Priority to PCT/PL2022/000021 priority patent/WO2022211649A1/en
Priority to EP22727512.0A priority patent/EP4313096A1/en
Publication of PL437487A1 publication Critical patent/PL437487A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)

Abstract

Przedmiotem wynalazku jest kompozycja farmaceutyczna, która zawiera jako składnik aktywny mieszaninę ekstraktu z owocu bzu czarnego Sambucus nigra oraz ekstraktu z aronii Aronia melanocarpa w stosunku 2: 1. Przedmiotem wynalazku jest również zastosowanie tej kompozycji do wytwarzania suplementów diety do stosowania w terapii wspomagającej przy leczeniu chorób o podłożu wirusowym do użytku wewnętrznego (podawana doustnie).The subject of the invention is a pharmaceutical composition which contains as an active ingredient a mixture of elderberry extract Sambucus nigra and aronia melanocarpa extract in a ratio of 2: 1. The subject of the invention is also the use of this composition for the production of dietary supplements for use in adjunctive therapy in the treatment of diseases. with viral origin for internal use (administered orally).

PL437487A 2021-04-02 2021-04-02 Pharmaceutical composition and its antiviral application PL437487A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL437487A PL437487A1 (en) 2021-04-02 2021-04-02 Pharmaceutical composition and its antiviral application
PCT/PL2022/000021 WO2022211649A1 (en) 2021-04-02 2022-04-04 Pharmaceutical composition and its antiviral use
EP22727512.0A EP4313096A1 (en) 2021-04-02 2022-04-04 Pharmaceutical composition and its antiviral use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL437487A PL437487A1 (en) 2021-04-02 2021-04-02 Pharmaceutical composition and its antiviral application

Publications (1)

Publication Number Publication Date
PL437487A1 true PL437487A1 (en) 2022-10-03

Family

ID=83724314

Family Applications (1)

Application Number Title Priority Date Filing Date
PL437487A PL437487A1 (en) 2021-04-02 2021-04-02 Pharmaceutical composition and its antiviral application

Country Status (1)

Country Link
PL (1) PL437487A1 (en)

Similar Documents

Publication Publication Date Title
CO5640037A2 (en) DERIVATIVES OF QUINAZOLINE FOR THE TREATMENT OF CANCER
RU2010105122A (en) COMPOSITIONS FOR CARE OF THE ORAL CAVITY, PRODUCTS AND METHODS OF APPLICATION
EA201290395A1 (en) IMMUNOMODULATING POLYPEPTIDES OBTAINED FROM IL-2 AND THEIR USE FOR THE TREATMENT OF CANCER AND CHRONIC INFECTIONS
BR112013001717A2 (en) Acquired Immunodeficiency Syndrome (AIDS) Treatment with Aloe Vera Antiviral Properties
BR112015019264A8 (en) capsules for the treatment of helicobacter pylori and their use ".
ES2462553A1 (en) Composition for improvement of sexual well-being (Machine-translation by Google Translate, not legally binding)
WO2018089328A8 (en) Treatment of cns diseases with sgc stimulators
BR0308713A (en) Dha and rosemary co-spherical, and methods of use
CR20230532A (en) Sgc stimulators
PL437487A1 (en) Pharmaceutical composition and its antiviral application
CN116600794A (en) Chenopodin compositions and methods for the treatment and prevention of covd-19 and related pathologies
BRPI0415322A (en) antiretroviral pharmaceutical composition, process for the preparation of an antiretroviral pharmaceutical composition, method for reducing the burden of pill consumption for a patient, method for increasing lamivudine and zidovudine half-life while not affecting nevirapine half-life
RU2005125411A (en) APPLICATION OF CONGLUTIN FOR TREATMENT OF TYPE II DIABETES
EA200501621A1 (en) ANTIGRIPOUS AGENT
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
MY191983A (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
MX2023001572A (en) Solid dosage forms of palbociclib.
PL425832A1 (en) Genistein and its composition to be used in treatment of Alzheimer disease
PL439058A1 (en) Antiviral use of a preparation
ES2809463T3 (en) Composition of natural anti-flu antioxidants
ATE259778T1 (en) NON-HYGROSCOPIC SALTS OF ACTIVE INGREDIENTS HAVING THERAPEUTIC AND/OR NUTRITIONAL PROPERTIES AND ORAL COMPOSITIONS CONTAINING SAME
ES2211374T1 (en) METRONOMIC DOSAGE OF TAXANES TO INHIBIT TUMOR GROWTH.
Pereira et al. Bioengineering applied to gastric cancer management
CR20220453A (en) Compositions of vitamin a palmitate, processes for their preparation, uses and methods comprising them
PL425242A1 (en) Application of 3'-amino-4-carboxychalcone